NYSE:KODKodiak Sciences Stock Price, Forecast & News

Kodiak Sciences' stock was trading at $53.85 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, KOD shares have increased by 22.7% and is now trading at $66.05. View which stocks have been most impacted by Coronavirus.

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Kodiak Sciences in the last year. There are currently 1 hold rating and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Kodiak Sciences.

Kodiak Sciences is scheduled to release its next quarterly earnings announcement on Wednesday, August 12th 2020. View our earnings forecast for Kodiak Sciences.

Kodiak Sciences Inc. (NYSE:KOD) released its earnings results on Monday, May, 11th. The company reported ($0.54) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.47) by $0.07. View Kodiak Sciences' earnings history.

10 equities research analysts have issued 12-month price targets for Kodiak Sciences' stock. Their forecasts range from $40.00 to $115.00. On average, they expect Kodiak Sciences' stock price to reach $83.00 in the next year. This suggests a possible upside of 25.7% from the stock's current price. View analysts' price targets for Kodiak Sciences.

Headlines about KOD stock have been trending positive on Friday, according to InfoTrie Sentiment Analysis. InfoTrie identifies positive and negative press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Kodiak Sciences earned a media sentiment score of 3.0 on InfoTrie's scale. They also gave news articles about the company a news buzz of 4.0 out of 10, indicating that recent press coverage is somewhat unlikely to have an effect on the company's share price in the next several days. View the latest news aboutKodiak Sciences.

Some companies that are related to Kodiak Sciences include MORGAN STANLEY Morgan Stanley Capital Protected Notes Based on S&P 500 (MOR), MorphoSys (MOR), Vir Biotechnology (VIR), MorphoSys (MOR), BTG (BTG), Abcam (ABC), Cronos Group (CRON), Viela Bio (VIE), Genus (GNS), Mesoblast (MSB), Polynovo (PNV), NGM Biopharmaceuticals (NGM), Concordia International (CXR), Clinuvel Pharmaceuticals (CUV) and BELLUS Health (BLU). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Kodiak Sciences investors own include Johnson & Johnson (JNJ), AbbVie (ABBV), NVIDIA (NVDA), Alibaba Group (BABA), Cisco Systems (CSCO), Inovio Pharmaceuticals (INO), Square (SQ), AT&T (T), Walt Disney (DIS) and CVS Health (CVS).

(KOD) raised $126 million in an IPO on Thursday, October 4th 2018. The company issued 9,000,000 shares at $13.00-$15.00 per share. Morgan Stanley and BofA Merrill Lynch acted as the underwriters for the IPO and Barclays and Chardan were co-managers.

Kodiak Sciences trades on the New York Stock Exchange (NYSE) under the ticker symbol "KOD."

Kodiak Sciences' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Wellington Management Group LLP (7.10%), BlackRock Inc. (5.80%), ArrowMark Colorado Holdings LLC (2.81%), State Street Corp (1.70%), Geode Capital Management LLC (0.91%) and Driehaus Capital Management LLC (0.66%). Company insiders that own Kodiak Sciences stock include Bros Advisors Lp Baker, Hong Liang, Jason Ehrlich, Richard S Levy and Robert Profusek. View institutional ownership trends for Kodiak Sciences.

KOD stock was sold by a variety of institutional investors in the last quarter, including ArrowMark Colorado Holdings LLC, Wellington Management Group LLP, Invesco Ltd., Russell Investments Group Ltd., Morgan Stanley, Morgan Stanley, UBS Group AG, and Federated Hermes Inc.. Company insiders that have sold Kodiak Sciences company stock in the last year include Hong Liang, and Jason Ehrlich. View insider buying and selling activity for Kodiak Sciences.

KOD stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Driehaus Capital Management LLC, State Street Corp, Geode Capital Management LLC, Two Sigma Investments LP, Nuveen Asset Management LLC, Tekla Capital Management LLC, and Mutual of America Capital Management LLC. Company insiders that have bought Kodiak Sciences stock in the last two years include Bros Advisors Lp Baker, Richard S Levy, and Robert Profusek. View insider buying and selling activity for Kodiak Sciences.

Shares of KOD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of KOD stock can currently be purchased for approximately $66.05.

Kodiak Sciences has a market capitalization of $2.94 billion.

The official website for Kodiak Sciences is www.kodiak.com.

The company can be reached via phone at 650-281-0850.